The effect of ureteropelvic junction obstruction and pyeloplasty on somatic growth during infancy.

IF 2.6 4区 医学 Q2 UROLOGY & NEPHROLOGY
Eyal Kord, Binyamin B Neeman, Dolev Perez, Boris Chertin, Amnon Zisman, Amos Neheman
{"title":"The effect of ureteropelvic junction obstruction and pyeloplasty on somatic growth during infancy.","authors":"Eyal Kord,&nbsp;Binyamin B Neeman,&nbsp;Dolev Perez,&nbsp;Boris Chertin,&nbsp;Amnon Zisman,&nbsp;Amos Neheman","doi":"10.1177/17562872231172835","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Evidence regarding the impact of perinatal ureteropelvic junction obstruction (UPJO) and surgical correction during infancy, on somatic growth are scarce. Understanding these impacts could help advise parents and aid in treatment decision making.</p><p><strong>Objectives: </strong>To assess the impact of unilateral UPJO and surgical correction on somatic growth in infants diagnosed antenatally and treated during infancy.</p><p><strong>Design: </strong>A retrospective bi-institutional analysis of somatic growth in patients under 2 years who underwent dismembered pyeloplasty for the treatment of UPJO was conducted.</p><p><strong>Methods: </strong>We evaluated patients who were diagnosed with unilateral hydronephrosis during pre-natal ultrasound screening for detection of fetal anomalies between May 2015 and October 2020. The height and weight of patients who were diagnosed with UPJO were recorded at the age of 1 month, time of surgery, and 6 months after surgery. Standard deviation scores (SDSs) for height and weight were calculated and compared.</p><p><strong>Results: </strong>Forty-eight patients under the age of 2 years were included in the analysis. Median age and weight at pyeloplasty were 6.9 months and 7.5 kg. At 1 month, the median SDS for weight in the entire cohort was -0.30 [interquartile range (IQR): -1.0 to 0.63] and the median SDS for height was -0.26 (IQR: -1.08 to 0.52). In 22.9% of patients (11/48), weight and height were below -1 age-appropriate standard deviations, and 6.3% (3/48) were below -2 standard deviations, suggesting growth restriction. When comparing SDS for the entire cohort, there was no significant difference corelated to measurement time or effect of surgery. In the growth restricted cohort, we found a significant improvement in linear growth for height, which was demonstrated between birth and surgery as well as after surgery.</p><p><strong>Conclusion: </strong>Infants with unilateral UPJO diagnosed antenatally as a single anomaly may be at an increased risk of somatic growth restriction in comparison with the general population. In children with growth restriction at time of birth, height seems to improve regardless of surgical treatment. Pyeloplasty during infancy does not seem to negatively affect somatic growth. These findings can be used to counsel parents regarding the potential effects of UPJO and pyeloplasty.</p>","PeriodicalId":23010,"journal":{"name":"Therapeutic Advances in Urology","volume":null,"pages":null},"PeriodicalIF":2.6000,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/ba/93/10.1177_17562872231172835.PMC10201135.pdf","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Therapeutic Advances in Urology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1177/17562872231172835","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"UROLOGY & NEPHROLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Evidence regarding the impact of perinatal ureteropelvic junction obstruction (UPJO) and surgical correction during infancy, on somatic growth are scarce. Understanding these impacts could help advise parents and aid in treatment decision making.

Objectives: To assess the impact of unilateral UPJO and surgical correction on somatic growth in infants diagnosed antenatally and treated during infancy.

Design: A retrospective bi-institutional analysis of somatic growth in patients under 2 years who underwent dismembered pyeloplasty for the treatment of UPJO was conducted.

Methods: We evaluated patients who were diagnosed with unilateral hydronephrosis during pre-natal ultrasound screening for detection of fetal anomalies between May 2015 and October 2020. The height and weight of patients who were diagnosed with UPJO were recorded at the age of 1 month, time of surgery, and 6 months after surgery. Standard deviation scores (SDSs) for height and weight were calculated and compared.

Results: Forty-eight patients under the age of 2 years were included in the analysis. Median age and weight at pyeloplasty were 6.9 months and 7.5 kg. At 1 month, the median SDS for weight in the entire cohort was -0.30 [interquartile range (IQR): -1.0 to 0.63] and the median SDS for height was -0.26 (IQR: -1.08 to 0.52). In 22.9% of patients (11/48), weight and height were below -1 age-appropriate standard deviations, and 6.3% (3/48) were below -2 standard deviations, suggesting growth restriction. When comparing SDS for the entire cohort, there was no significant difference corelated to measurement time or effect of surgery. In the growth restricted cohort, we found a significant improvement in linear growth for height, which was demonstrated between birth and surgery as well as after surgery.

Conclusion: Infants with unilateral UPJO diagnosed antenatally as a single anomaly may be at an increased risk of somatic growth restriction in comparison with the general population. In children with growth restriction at time of birth, height seems to improve regardless of surgical treatment. Pyeloplasty during infancy does not seem to negatively affect somatic growth. These findings can be used to counsel parents regarding the potential effects of UPJO and pyeloplasty.

Abstract Image

Abstract Image

Abstract Image

肾盂输尿管连接处梗阻及肾盂成形术对婴儿体发育的影响。
背景:关于围产期肾盂输尿管连接处梗阻(UPJO)和婴儿期手术矫正对躯体生长影响的证据很少。了解这些影响可以为家长提供建议,并有助于治疗决策。目的:评估单侧UPJO和手术矫正对产前诊断和婴儿期治疗的婴儿躯体生长的影响。设计:对2岁以下接受肢解肾盂成形术治疗UPJO的患者进行躯体生长的回顾性双机构分析。方法:对2015年5月至2020年10月期间在产前超声检查中诊断为单侧肾积水的胎儿畸形患者进行评估。记录UPJO患者1月龄、手术时间、术后6个月的身高、体重。计算并比较身高和体重的标准差得分(SDSs)。结果:48例2岁以下患者纳入分析。肾盂成形术时的中位年龄和体重分别为6.9个月和7.5公斤。在1个月时,整个队列中体重的中位SDS为-0.30[四分位数范围(IQR): -1.0至0.63],身高的中位SDS为-0.26 (IQR: -1.08至0.52)。22.9%(11/48)的患者体重和身高低于-1适龄标准差,6.3%(3/48)的患者体重和身高低于-2适龄标准差,提示生长受限。当比较整个队列的SDS时,没有与测量时间或手术效果相关的显著差异。在生长受限队列中,我们发现身高的线性增长有显著改善,这在出生和手术之间以及手术后都得到了证明。结论:与一般人群相比,产前诊断为单侧UPJO的婴儿可能有更高的躯体生长受限风险。在出生时生长受限的儿童中,无论手术治疗,身高似乎都有所提高。婴儿期的肾盂成形术似乎对躯体生长没有负面影响。这些发现可用于就UPJO和肾盂成形术的潜在影响向家长提供咨询。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
3.70
自引率
0.00%
发文量
39
审稿时长
10 weeks
期刊介绍: Therapeutic Advances in Urology delivers the highest quality peer-reviewed articles, reviews, and scholarly comment on pioneering efforts and innovative studies across all areas of urology. The journal has a strong clinical and pharmacological focus and is aimed at clinicians and researchers in urology, providing a forum in print and online for publishing the highest quality articles in this area. The editors welcome articles of current interest across all areas of urology, including treatment of urological disorders, with a focus on emerging pharmacological therapies.
文献相关原料
公司名称 产品信息 采购帮参考价格
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信